168 related articles for article (PubMed ID: 17966430)
1. Enrichment of Yersinia pestis from blood cultures enables rapid antimicrobial susceptibility determination by flow cytometry.
Steinberger-Levy I; Zahavy E; Cohen S; Flashner Y; Mamroud E; Aftalion M; Gur D; Ber R
Adv Exp Med Biol; 2007; 603():339-50. PubMed ID: 17966430
[TBL] [Abstract][Full Text] [Related]
2. Rapid Antibiotic Susceptibility Determination for Yersinia pestis Using Flow Cytometry Spectral Intensity Ratio (SIR) Fluorescence Analysis.
Zahavy E; Rotem S; Gur D; Aloni-Grinstein R; Aftalion M; Ber R
J Fluoresc; 2018 Sep; 28(5):1151-1161. PubMed ID: 30117073
[TBL] [Abstract][Full Text] [Related]
3. Laboratory studies on Yersinia pestis during the 1991 outbreak of plague in Lushoto, Tanzania.
Lyamuya EF; Nyanda P; Mohammedali H; Mhalu FS
J Trop Med Hyg; 1992 Oct; 95(5):335-8. PubMed ID: 1404556
[TBL] [Abstract][Full Text] [Related]
4. Rapid identification and antibiotic susceptibility testing of Yersinia pestis using bioluminescent reporter phage.
Schofield DA; Molineux IJ; Westwater C
J Microbiol Methods; 2012 Aug; 90(2):80-2. PubMed ID: 22579583
[TBL] [Abstract][Full Text] [Related]
5. Rapid detection and simultaneous antibiotic susceptibility analysis of Yersinia pestis directly from clinical specimens by use of reporter phage.
Vandamm JP; Rajanna C; Sharp NJ; Molineux IJ; Schofield DA
J Clin Microbiol; 2014 Aug; 52(8):2998-3003. PubMed ID: 24920765
[TBL] [Abstract][Full Text] [Related]
6. Development and evaluation of loop-mediated isothermal amplification for detection of Yersinia pestis in plague biological samples.
Randriantseheno LN; Rahantamalala A; Randrianierenana AL; Rajerison M; Andrianaivoarimanana V
PLoS One; 2020; 15(8):e0237655. PubMed ID: 32810167
[TBL] [Abstract][Full Text] [Related]
7. Plague: Recognition, Treatment, and Prevention.
Yang R
J Clin Microbiol; 2018 Jan; 56(1):. PubMed ID: 29070654
[TBL] [Abstract][Full Text] [Related]
8. Bacterial filamentation of Yersinia pestis by beta-lactam antibiotics in experimentally infected mice.
Davis KJ; Vogel P; Fritz DL; Steele KE; Pitt ML; Welkos SL; Friedlander AM; Byrne WR
Arch Pathol Lab Med; 1997 Aug; 121(8):865-8. PubMed ID: 9278616
[TBL] [Abstract][Full Text] [Related]
9. Use of an in vitro pharmacodynamic model to derive a moxifloxacin regimen that optimizes kill of Yersinia pestis and prevents emergence of resistance.
Louie A; Heine HS; VanScoy B; Eichas A; Files K; Fikes S; Brown DL; Liu W; Kinzig-Schippers M; Sörgel F; Drusano GL
Antimicrob Agents Chemother; 2011 Feb; 55(2):822-30. PubMed ID: 21115791
[TBL] [Abstract][Full Text] [Related]
10. [The sensitivity of plague agent from Siberian natural focuses of disease to antibacterial preparations in vitro].
Balakhonov SV; Bel'kova SA; Tokmakova EG; Khvoĭnova IG; Zakhlebnaia OD
Klin Lab Diagn; 2013 Apr; (4):36-40. PubMed ID: 23984554
[TBL] [Abstract][Full Text] [Related]
11. In vitro activities of 14 antibiotics against 100 human isolates of Yersinia pestis from a southern African plague focus.
Frean JA; Arntzen L; Capper T; Bryskier A; Klugman KP
Antimicrob Agents Chemother; 1996 Nov; 40(11):2646-7. PubMed ID: 8913481
[TBL] [Abstract][Full Text] [Related]
12. [Plague in Algeria: about five strains of Yersinia pestis isolated during the outbreak of June 2003].
Lounici M; Lazri M; Rahal K
Pathol Biol (Paris); 2005 Feb; 53(1):15-8. PubMed ID: 15620604
[TBL] [Abstract][Full Text] [Related]
13. Multidrug resistance in Yersinia pestis mediated by a transferable plasmid.
Galimand M; Guiyoule A; Gerbaud G; Rasoamanana B; Chanteau S; Carniel E; Courvalin P
N Engl J Med; 1997 Sep; 337(10):677-80. PubMed ID: 9278464
[No Abstract] [Full Text] [Related]
14. Antibiotic susceptibilities of 94 isolates of Yersinia pestis to 24 antimicrobial agents.
Hernandez E; Girardet M; Ramisse F; Vidal D; Cavallo JD
J Antimicrob Chemother; 2003 Dec; 52(6):1029-31. PubMed ID: 14613959
[TBL] [Abstract][Full Text] [Related]
15. Long-term persistence of virulent Yersinia pestis in soil.
Ayyadurai S; Houhamdi L; Lepidi H; Nappez C; Raoult D; Drancourt M
Microbiology (Reading); 2008 Sep; 154(Pt 9):2865-2871. PubMed ID: 18757820
[TBL] [Abstract][Full Text] [Related]
16. Development of an improved selective agar medium for isolation of Yersinia pestis.
Ber R; Mamroud E; Aftalion M; Tidhar A; Gur D; Flashner Y; Cohen S
Appl Environ Microbiol; 2003 Oct; 69(10):5787-92. PubMed ID: 14532026
[TBL] [Abstract][Full Text] [Related]
17. [A method for the accelerated determination of the virulence of Y. pestis cultures in the epizootiological examination of natural plague foci].
Orlov GS
Voen Med Zh; 1993 Feb; (2):39-41, 80. PubMed ID: 8498023
[TBL] [Abstract][Full Text] [Related]
18. Persistence of Yersinia pestis in soil under natural conditions.
Eisen RJ; Petersen JM; Higgins CL; Wong D; Levy CE; Mead PS; Schriefer ME; Griffith KS; Gage KL; Beard CB
Emerg Infect Dis; 2008 Jun; 14(6):941-3. PubMed ID: 18507908
[TBL] [Abstract][Full Text] [Related]
19. In vitro antimicrobial susceptibilities of strains of Yersinia pestis.
Smith MD; Vinh DX; Nguyen TT; Wain J; Thung D; White NJ
Antimicrob Agents Chemother; 1995 Sep; 39(9):2153-4. PubMed ID: 8540736
[TBL] [Abstract][Full Text] [Related]
20. Impact of resistance selection and mutant growth fitness on the relative efficacies of streptomycin and levofloxacin for plague therapy.
Louie A; Deziel MR; Liu W; Drusano GL
Antimicrob Agents Chemother; 2007 Aug; 51(8):2661-7. PubMed ID: 17517837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
